Ionis’s ION373 an Orphan Drug in U.S. for a uncommon neurodegenerative illness (NASDAQ:IONS)


The FDA has designated Orphan Drug standing to Ionis Prescription drugs’s (NASDAQ:IONS) ION373 for the therapy of Alexander illness, a uncommon neurodegenerative illness, characterised by the destruction of the myelin sheath (fatty protecting that protects the nerve fiber and helps sign conduction).

Alexander illness is brought on by a mutation in a protein leading to overproduction of glial fibrillary acidic protein (GFAP) within the mind, and ION373 is antisense medication designed to cease the mutated gene from producing extra GFAP.


Please enter your comment!
Please enter your name here